NIZAMUDIN, M.; KUMAR, M. P.; GAUTHAM, A.; SRIRAM, D. K.; GEORGE, M. Roflumilast: First approved oral selective PDE4 inhibitor for the treatment of COPD. International Journal of Health and Clinical Research, [S. l.], v. 3, n. 5, p. 85–89, 2020. Disponível em: https://www.ijhcr.com/index.php/ijhcr/article/view/157. Acesso em: 14 dec. 2025.